Skip to main content
. 2024 Jun 11;109(8):1385–1394. doi: 10.1113/EP091680

FIGURE 1.

FIGURE 1

(a) Flow‐mediated dilatation (FMD) at baseline (n = 11), 1 h post‐completion (1HP, n = 9) and 24 h post‐completion (24HP, n = 10). (b) Baseline brachial artery diameter at baseline (n = 11), 1HP (n = 9) and 24HP (n = 10). (c) Peak shear rate area under the curve (Peak SR AUC) at baseline (n = 11), 1HP (n = 8) and 24HP (n = 10). (d) FMD normalized to peak SR AUC with outlier at baseline (n = 11), 1HP (n = 8) and 24HP (n = 10). (e) FMD normalized to peak SR AUC without outlier at baseline (n = 11), 1HP (n = 7) and 24HP (n = 10). Bars indicate means ± SD. Significant difference from baseline: *P < 0.05, **P < 0.001. FMD: 1HP versus BL, P = 0.742; 24HP versus BL, P = 0.412. Baseline brachial artery diameter: 1HP versus BL, P = 0.843; 24HP versus BL, P = 0.650. Peak SR AUC: 1HP versus BL, P < 0.001; 24HP versus BL, P = 0.149. Normalized FMD (with outlier): 1HP versus BL, P = 0.067; 24HP versus BL, P = 0.697. Normalized FMD (without outlier): 1HP versus BL, P = 0.002; 24HP versus BL, P = 0.698.